**Core Concept**
Interstitial brachytherapy involves the placement of radioactive sources directly into or near tumors to deliver high doses of radiation locally. This technique is used to treat various cancers, including prostate, breast, and brain tumors. The choice of radioactive source depends on the type of cancer, tumor size, and location.

**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general principles of interstitial brachytherapy. Radioactive sources like **Iodine-125**, **Palladium-103**, and **Cesium-131** are commonly used in interstitial brachytherapy due to their suitable energies and half-lives for localized tumor treatment.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, we cannot directly address why it might be incorrect. However, if it were a source like **Radium-226**, it might be less commonly used today due to its longer half-life and higher energy radiation.
**Option B:** Similarly, without specifics, if option B were **Gold-198**, it's an older source that has been largely replaced by more modern isotopes with better characteristics for brachytherapy.
**Option C:** If option C were **Iridium-192**, it's actually used in high-dose-rate (HDR) brachytherapy rather than interstitial (low-dose-rate) brachytherapy, making it an incorrect choice for the context of the question as stated.
**Option D:** Without knowing what option D is, we can't comment on its suitability for interstitial brachytherapy.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that the choice of isotope in brachytherapy depends on the specific clinical scenario, including the type and location of the tumor, as well as the desired dose rate. **Iodine-125** and **Palladium-103** are commonly used for prostate cancer due to their low energy and suitable half-lives.

**Correct Answer:** Not provided in the query.